CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
2.010
-0.090 (-4.29%)
At close: Dec 5, 2025, 4:00 PM EST
2.050
+0.040 (1.99%)
After-hours: Dec 5, 2025, 5:55 PM EST
CollPlant Biotechnologies Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -12.16 | -16.61 | -7.02 | -16.93 | 0.24 | -5.77 | |
| Depreciation & Amortization | 0.94 | 1.04 | 1.1 | 1.08 | 0.77 | 0.66 | |
| Loss (Gain) From Sale of Assets | - | - | 0.02 | - | - | - | |
| Stock-Based Compensation | 1.44 | 1.72 | 1.94 | 2.17 | 1.6 | 1.67 | |
| Other Operating Activities | -0.15 | 0.13 | 0.35 | 0.52 | -0.32 | -0.1 | |
| Change in Accounts Receivable | -0.01 | -0.15 | 0.01 | 0.26 | 0.56 | -0.75 | |
| Change in Inventory | -0.08 | 0.28 | 0.75 | -0.31 | 0.18 | -0.37 | |
| Change in Accounts Payable | -0.39 | -0.11 | -0.15 | 0.1 | 0.24 | -0.04 | |
| Change in Unearned Revenue | - | - | - | -0.03 | -0.18 | -0.74 | |
| Change in Other Net Operating Assets | 0.46 | -0.39 | 0.24 | -0.56 | -0.59 | 0.98 | |
| Operating Cash Flow | -9.95 | -14.09 | -2.76 | -13.7 | 2.5 | -4.45 | |
| Capital Expenditures | -0.07 | -0.48 | -0.95 | -1.27 | -1.43 | -0.44 | |
| Sale of Property, Plant & Equipment | 0 | 0 | 0.07 | - | 0.03 | - | |
| Sale (Purchase) of Intangibles | - | - | - | -0.04 | -0.16 | -0.08 | |
| Investment in Securities | - | - | - | 30.24 | -30 | - | |
| Other Investing Activities | - | -0.06 | -0.27 | - | - | - | |
| Investing Cash Flow | -0.07 | -0.54 | -1.16 | 28.92 | -31.56 | -0.52 | |
| Long-Term Debt Repaid | - | - | - | - | - | -0.02 | |
| Net Debt Issued (Repaid) | - | - | - | - | - | -0.02 | |
| Issuance of Common Stock | 3.1 | 0.01 | 1.11 | 1.87 | 38.76 | 4.54 | |
| Other Financing Activities | - | - | - | - | - | -0.05 | |
| Financing Cash Flow | 3.1 | 0.01 | 1.11 | 1.87 | 38.76 | 4.47 | |
| Foreign Exchange Rate Adjustments | 0.09 | -0.14 | -0.38 | -0.61 | 0.14 | 0.06 | |
| Net Cash Flow | -6.82 | -14.77 | -3.19 | 16.49 | 9.85 | -0.45 | |
| Free Cash Flow | -10.02 | -14.58 | -3.72 | -14.97 | 1.07 | -4.89 | |
| Free Cash Flow Margin | -404.85% | -2830.29% | -33.92% | -5007.36% | 6.86% | -79.65% | |
| Free Cash Flow Per Share | -0.84 | -1.27 | -0.33 | -1.36 | 0.09 | -0.71 | |
| Cash Income Tax Paid | 0.06 | 0.06 | 0.01 | 0.03 | - | - | |
| Levered Free Cash Flow | -5.76 | -8.89 | -1.9 | -8.9 | 0.94 | -2.82 | |
| Unlevered Free Cash Flow | -5.76 | -8.89 | -1.9 | -8.89 | 0.95 | -2.81 | |
| Change in Working Capital | -0.02 | -0.37 | 0.85 | -0.54 | 0.22 | -0.91 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.